Methods and compositions in breast cancer diagnosis and therapeutics
US6821732B2 · kind B2 · utility
3Cited by
2References
14Claims
0Family size
Inventors
Key dates
| Filing date | Jan 18, 2002 |
| Grant date | Nov 23, 2004 |
| Priority date | — |
| Expiry date | Jan 18, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.